微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Enteric group 137 |
|---|---|
| 商品货号： | TS143334 |
| Strain Designations： | CDC 2411-97 |
| Application： | Produces extended spectrum beta-lactamase (ESBL) |
| Isolation： | Human urine, Chicago, IL, 1997 |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Preceptrol®： | no |
| Type Strain： | no |
| Antibiotic Resistance： | Resistant to ampicillin Resistant to aztreonam Resistant to cefazolin Resistant to ceftazidime Resistant to cephalothin Resistant to piperacillin Sensitive to ampicillin-sulbactam Sensitive to cefotetan Sensitive to imipenem Sensitive to piperacillin-tazobactam |
| Medium： | ATCC® Medium 18: Trypticase Soy Agar/Broth |
| Growth Conditions： | Temperature: 37.0°C Atmosphere: aerobic |
| Name of Depositor： | NA Strockbine |
| Special Collection： | NCRR Contract |
| Chain of Custody： | ATCC < |
| Year of Origin： | 1997 |
| References： | Warren JR, et al. Outbreak of nosocomial infections due to extended-spectrum beta- lactamase-producing strains of enteric group 137, a new member of the family enterobacteriaceae closely related to citrobacter farmeri and citrobacter amalonaticus. J. Clin. Microbiol. 38: 3946-3952, 2000. PubMed: 11060050 |